303 related articles for article (PubMed ID: 15765978)
1. [Hepatocyte growth factor (HGF) and its therapeutic applications].
Segura-Flores AA; Gálvez-Gastélum FJ; Alvarez-Rodríguez A; Armendáriz-Borunda J
Rev Gastroenterol Mex; 2004; 69(4):243-50. PubMed ID: 15765978
[TBL] [Abstract][Full Text] [Related]
2. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles.
Jiang WG; Hiscox S
Histol Histopathol; 1997 Apr; 12(2):537-55. PubMed ID: 9151142
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor activator: a possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract.
Matsubara Y; Ichinose M; Yahagi N; Tsukada S; Oka M; Miki K; Kimura S; Omata M; Shiokawa K; Kitamura N; Kaneko Y; Fukamachi H
Biochem Biophys Res Commun; 1998 Dec; 253(2):477-84. PubMed ID: 9878561
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
Nakamura T
Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
[TBL] [Abstract][Full Text] [Related]
6. The role of hepatocyte growth factor/c-met interactions in the immune system.
Skibinski G
Arch Immunol Ther Exp (Warsz); 2003; 51(5):277-82. PubMed ID: 14626426
[TBL] [Abstract][Full Text] [Related]
7. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
Nagashima M; Hasegawa J; Kato K; Yamazaki J; Nishigai K; Ishiwata T; Asano G; Yoshino S
J Rheumatol; 2001 Aug; 28(8):1772-8. PubMed ID: 11508578
[TBL] [Abstract][Full Text] [Related]
9. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
[TBL] [Abstract][Full Text] [Related]
10. Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1).
Kataoka H; Itoh H; Hamasuna R; Meng JY; Koono M
Hum Cell; 2001 Mar; 14(1):83-93. PubMed ID: 11436357
[TBL] [Abstract][Full Text] [Related]
11. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor.
Miyazawa K
FEBS J; 2010 May; 277(10):2208-14. PubMed ID: 20402766
[TBL] [Abstract][Full Text] [Related]
13. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
[TBL] [Abstract][Full Text] [Related]
14. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
Christensen JG; Burrows J; Salgia R
Cancer Lett; 2005 Jul; 225(1):1-26. PubMed ID: 15922853
[TBL] [Abstract][Full Text] [Related]
15. Isoforms of human HGF and their biological activities.
Chan A; Rubin J; Bottaro D; Hirschfield D; Chedid M; Aaronson SA
EXS; 1993; 65():67-79. PubMed ID: 8380745
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
17. Increase in the beta chain of hepatocyte growth factor (HGF beta) precedes c-met expression after bleomycin-induced lung injury in the rat.
Douglas D; Chen G; Khalil N
Exp Lung Res; 2002 Jun; 28(4):301-14. PubMed ID: 12042032
[TBL] [Abstract][Full Text] [Related]
18. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury.
Kitamura K; Iwanami A; Nakamura M; Yamane J; Watanabe K; Suzuki Y; Miyazawa D; Shibata S; Funakoshi H; Miyatake S; Coffin RS; Nakamura T; Toyama Y; Okano H
J Neurosci Res; 2007 Aug; 85(11):2332-42. PubMed ID: 17549731
[TBL] [Abstract][Full Text] [Related]
20. Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor.
Fukuta K; Matsumoto K; Nakamura T
Biochem J; 2005 Jun; 388(Pt 2):555-62. PubMed ID: 15693751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
